...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New PP on SEDAR

Was just checking SEDAR and found new PPs that totalled about 730k. The bulk was from one investor in Hong Kong. That brings a total investment into Zenith to about 3M since the beginning of the year. The latest PP, each unit is 1 share and a half warrant for $1.38. What I found interesting is that the warrants expire this November. Don was suggesting at the AGM that investors might see money coming their way in November. This short expiration date might support that this is managements actual belief or maybe it's just a typo. Would be nice to see something Don said actually come to pass, it has been a verrrrry long time since that happened. 

Share
New Message
Please login to post a reply